500
Participants
Start Date
May 31, 2024
Primary Completion Date
January 1, 2031
Study Completion Date
December 31, 2031
Radical prostatectomy
Removal of the prostate and seminal vesicles.
Prostate irradiation
Radiation therapy of the prostate.
Surgical metastasectomy
Surgical removal of metastases.
Irradiation of metastases
Radiation therapy of metastases.
Abiraterone acetate
Administered as part of multimodal treatment for oligometastatic prostate cancer
Enzalutamide
Administered as part of multimodal treatment for oligometastatic prostate cancer
Darolutamide
Administered as part of multimodal treatment for oligometastatic prostate cancer
Apalutamide
Administered as part of multimodal treatment for oligometastatic prostate cancer
Docetaxel
Administered as part of multimodal treatment for oligometastatic prostate cancer
Lutetium-PSMA
Administered as part of multimodal treatment for oligometastatic prostate cancer
Androgen deprivation treatment
Administered as part of multimodal treatment for oligometastatic prostate cancer
IRCCS Ospedale San Raffaele
OTHER
University Hospital of Cologne
OTHER
St. Antonius Hospital
OTHER
Istituto Europeo di Oncologia
OTHER
University Hospital, Udine, Italy
OTHER
Azienda Ospedaliera San Giovanni Battista
OTHER
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
OTHER
Lund University
OTHER
Medical University of Warsaw
OTHER
Ziekenhuis Netwerk Antwerpen (ZNA)
OTHER
Medical University of Vienna
OTHER